← Back to news

Markets

FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT)

Y

Strong Rare Disease Pipeline Drives Favorable Sentiment for Ultragenyx (RARE)

Y

Wave Life Sciences (WVE) to Benefit From Optimism Surrounding Alpha-1 Antitrypsin Deficiency Program

Y

Dyne Therapeutics (DYN) Attains Orphan Drug Designation From Japanese Ministry

Y

Impressive Clinical Pipeline Leads to Bullish Sentiment for Vaxcyte (PCVX)

Y

Stifel Initiates Coverage on Olema Pharmaceuticals (OLMA) With Buy Rating

Y

Here is Why Beam Therapeutics (BEAM) Appears so Attractive

Y

Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX)

Y

Orexin-2 Receptor Data Reinforces a Positive Outlook for Centessa (CNTA)

Y

Spyre Therapeutics (SYRE) Set POC Readout Priorities for 2026

Y

Atacicept’s Potential Approval Drives Favorable Views on Vera Therapeutics (VERA)

Y

Arcellx (ACLX) Shares Encouraging Data on Latest Laboratory Study

Y

Here is Why Apogee Therapeutics (APGE) Appears Attractive

Y

Timely Tips And Tools On How To Invest In Stocks In This Market

Y

Prediction: 2 Stocks That Will Be Worth More Than Amazon 3 Years From Now

Y

Apollo Global Management Touts $40T Private Credit Opportunity, AI Financing and Fund XI at BofA Conference

Y

Micron: Nothing Is Over

S

They're Complete Opposites. He Saved More Than $100K And Pays For Everything, While She's $80K In Debt. 'I Ain't Saying She's The Gold Digger'

Y

Great Wall Motor plans Europe relaunch with hybrids and local plant

Y

Gold, XRP extend losses on Presidents’ Day

Y

This AI Stock Just Became Wall Street's Most Controversial Pick for 2026

Y

Bitcoin 'Boom-Bust' Era Is Over as Institutions Take the Lead: WisdomTree

Y

3 Stock Updates You'll Want to Watch This Week

Y

UBS Still Neutral on East West Bank (EWBC)

Y

UBS Retained Buy Recommendation on SouthState Bank (SSB)

Y

Commerce Bank (CBSH) Declares Dividends of $0.2750 per Share

Y

UBS Keeps Buy Rating on Western Alliance (WAL)

Y

JP Morgan Increases Target Price on Huntington Bancshares (HBAN) to $21

Y

Evercore ISI Raises Price Target on Pinnacle Financial (PNFP) to $116, Keeps Overweight Call

Y

JP Morgan Raises Target Price on Truist Financial (TFC) to $47, Keeps Neutral Call

Y

JP Morgan Overweight on BNY Mellon (BK) with a Target Price of $128.50

Y

Baird Upgrades Wells Fargo (WFC) to Neutral

Y

JP Morgan Raises Target Price on Citi (C), Keeps Overweight Call

Y

1 Incredible Growth Stock to Buy Right Now With $200

Y

Analyst sends stark $120 billion AI warning

Y

Paying Off Debt Is Lonely? 'There Is No Applause For Discipline, No Encouragement When Motivation Drops'

Y

Pudgy Penguins (PENGU) Lifts After Visa Debit Card Reveal: What You Should Know

Y

Harvard Cuts Bitcoin ETF Stake, Adds Ethereum Exposure in Q4 Filing

Y

Taiwan Semiconductor Manufacturing (TSM) Positioned to Benefit From AI Demand and Potential Pricing Power

Y

Medlog opens new Saudi logistics park

Y

Is the Vanguard Dividend Appreciation ETF a Buy Now?

Y

Britons say they need nearly £9,000 in cash before opening Stocks and Shares ISA, research finds

Y

Liquidia Corporation (LQDA) Gains Momentum Following Overturning of District Court Patent Ruling

Y

Legendary skeptic delivers 6-word verdict on Palantir’s hot streak

Y

'I'm Worth $7.3 Million,' Physician Says — Yet A $3 Drink For His Kids Gives Him Pause As 'Ramsey Show' Host Urges Him To 'Loosen The Purse Strings'

Y

Barry Silbert Forecasts Up To 10% Of Bitcoin's Market Cap Will Move To Privacy Coins—Crypto Mogul Says Zcash Can Rocket 500x, BTC Won't

Y

Apollo Global Management CFO Sees Higher Rates Ahead as Origination Hits $300B, FRE Jumps 23%

Y

Broker continues to see substantial upside as Pantheon Resources kicks off fresh work at Kodiak

Y

Fabrinet (FN) Advances as Optical Hardware Demand Strengthens

Y

British pub operator Greene King plans fresh restructuring – report

Y